The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis

References

• BrownLMDevesaSSChowWHIncidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and ageJ Natl Cancer Inst2008100161184118718695138
   PubMed Web of Science ®Google Scholar
• LinYTotsukaYHeYEpidemiology of esophageal cancer in Japan and ChinaJ Epidemiol201323423324223629646
   PubMed Web of Science ®Google Scholar
• PennathurAGibsonMKJobeBALuketichJDOesophageal carcinomaLancet2013381986440041223374478
   PubMed Web of Science ®Google Scholar
• DempkeWRieCGrotheyASchmollHJCyclooxygenase-2: a novel target for cancer chemotherapy?J Cancer Res Clin Oncol2001127741141711469677
   PubMed Web of Science ®Google Scholar
• RizzoMTCyclooxygenase-2 in oncogenesisClin Chim Acta20114129–1067168721187081
   PubMed Web of Science ®Google Scholar
• TakatoriHNatsugoeSOkumuraHCyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinomaEur J Surg Oncol200834439740217553653
   PubMed Web of Science ®Google Scholar
• PrinsMJVerhageRJten KateFJvan HillegersbergRCyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinomaJ Gastrointest Surg201216595696622258871
   PubMed Web of Science ®Google Scholar
• BhandariPBatemanACMehtaRLPrognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagusBMC Cancer2006613416712734
   PubMedGoogle Scholar
• NozoeTEzakiTKabashimaABabaHMaeharaYSignificance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagusAm J Surg2005189111011515701502
   PubMedGoogle Scholar
• OkawaTNaomotoYNobuhisaTHeparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2Clin Cancer Res200511227995800516299228
   PubMed Web of Science ®Google Scholar
• LiuJFJamiesonGWuTCZhangSWWangQZDrewPCyclooxygenase-2 expression in squamous cell carcinoma of the esophagusDis Esophagus200619535035416984531
   PubMed Web of Science ®Google Scholar
• YoonMSNamTKLeeJSVEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinomaJ Korean Med Sci201126451352021468258
   PubMed Web of Science ®Google Scholar
• HashimotoNInayamaMFujishimaMShiozakiHClinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinomaHepatogastroenterology2007547575876017591056
   PubMedGoogle Scholar
• BuskensCJVan ReesBPSivulaAPrognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagusGastroenterology200212271800180712055587
   PubMedGoogle Scholar
• HeerenPPlukkerJvan DullemenHNapRHollemaHPrognostic role of cyclooxygenase-2 expression in esophageal carcinomaCancer Lett2005225228328915978332
   PubMed Web of Science ®Google Scholar
• HuangJXChenWCLinMClinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinomaDis Esophagus201225212112921762277
   PubMedGoogle Scholar
• FranceMDrewPADoddTWatsonDICyclooxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomyDis Esophagus200417213614015230726
   PubMedGoogle Scholar
• HuangWZFuJHWangDKOverexpression of cyclooxygenase-2 is associated with chemoradiotherapy resistance and prognosis in esophageal squamous cell carcinoma patientsDis Esophagus200821867968418459994
   PubMed Web of Science ®Google Scholar
• LiuWKJiangXYZhangMPZhangZXThe relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinomaEur J Gastroenterol Hepatol2010221677419730383
   PubMedGoogle Scholar
• XiHBaldusSEWarnecke-EberzUHigh cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancerClin Cancer Res200511238341834716322294
   PubMedGoogle Scholar
• YangZGuanBMenTFujimotoJXuXComparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patientsIn Vivo201327447348423812217
   PubMedGoogle Scholar
• KawabeAShimadaYUchidaSExpression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expressionOncology2002621465411810043
   PubMedGoogle Scholar
• KuoKTChowKCWuYCClinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinomaAnn Thorac Surg200376390991412963227
   PubMedGoogle Scholar
• ShammaAYamamotoHDokiYUp-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagusClin Cancer Res2000641229123810778945
   PubMedGoogle Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• KaseSOsakiMHonjoSExpression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinomaPathobiology2004712849214707443
   PubMedGoogle Scholar
• SivulaABuskensCJvan ReesBPPrognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagusInt J Cancer2005116690390815856454
   PubMedGoogle Scholar
• YangGZLiLDingHYZhouJSCyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-kappaB: an immunohistochemical studyExp Mol Pathol200579321421816202995
   PubMedGoogle Scholar
• MiyashitaMMakinoHKatsutaMCyclooxygenase-2 over-expression is associated with human esophageal squamous cell carcinomaJ Nippon Med Sch200673630831317220580
   PubMedGoogle Scholar
• ChenJWuFPeiHLAnalysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancerOncol Lett20151042197220326622818
   PubMedGoogle Scholar
• HuDZhangMWangSWangZHigh expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after Ivor Lewis esophagectomyThorac Cancer20167331031527148416
   PubMedGoogle Scholar
• PengQYangSLaoXMeta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studiesPLoS One201494e9479024733273
   PubMedGoogle Scholar
• WangZHeMXiaoZWuHWuYQuantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysisPLoS One2013812e8290724358237
   PubMedGoogle Scholar
• GroschSMaierTJSchiffmannSGeisslingerGCyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitorsJ Natl Cancer Inst2006981173674716757698
   PubMedGoogle Scholar
• EdelmanMJWatsonDWangXEicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy – Cancer and Leukemia Group B Trial 30203J Clin Oncol200826684885518281656
   PubMed Web of Science ®Google Scholar
• AntonarakisESHeathEIWalczakJRPhase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersJ Clin Oncol200927304986499319720908
   PubMedGoogle Scholar
• BundredNJCramerAMorrisJCyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trialClin Cancer Res20101651605161220179229
   PubMedGoogle Scholar
• BastiaannetESampieriKDekkersOMUse of aspirin postdiagnosis improves survival for colon cancer patientsBr J Cancer201210691564157022454078
   PubMed Web of Science ®Google Scholar
• ClearyJMMamonHJSzymonifkaJNeoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancerBMC Cancer20161646827412386
   PubMedGoogle Scholar
• LiLZhaoJWuZWangGChenGMeta-analysis: clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carcinomaAliment Pharmacol Ther200930658959619549265
   PubMed Web of Science ®Google Scholar